Standout Papers
Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Removing T-cell epitopes with computational protein design
2014 StandoutNobel
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
Normal gut microbiota modulates brain development and behavior
2011 Standout
Trastuzumab emtansine (T-DM1) renders HER2 + breast cancer highly susceptible to CTLA-4/PD-1 blockade
2015
A tyrosine-reactive irreversible inhibitor for glutathione S -transferase Pi (GSTP1)
2016
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
2017 StandoutNature
Perlecan Maintains the Integrity of Cartilage and Some Basement Membranes
1999
Depression
2018 Standout
Cell Surface Expression of HIP, a Novel Heparin/Heparan Sulfate-binding Protein, of Human Uterine Epithelial Cells and Cell Lines
1996
Complementary Expression of Hip, a Cell-surface Heparan Sulfate Binding Protein, and Perlecan at the Human Fetal-Maternal Interface1
1998
Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies
2002
Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma‐related mortality in elderly follicular lymphoma in the United States
2015
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
2016 Standout
Embryo Implantation
2000 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
mTOR Signaling in Growth Control and Disease
2012 Standout
Massively parallel manipulation of single cells and microparticles using optical images
2005 StandoutNature
Muscarinic Supersensitivity and Impaired Receptor Desensitization in G Protein–Coupled Receptor Kinase 5–Deficient Mice
1999 StandoutNobel
Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy
2011
Changes in Extracellular Matrix Components and Cytokeratins in the Endometrium during Goat Implantation
1999
Cascaded Optical Field Enhancement in Composite Plasmonic Nanostructures
2010 StandoutNobel
Targeted therapy in rare cancers—adopting the orphans
2012
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
Neurobiological Similarities in Depression and Drug Dependence: A Self-Medication Hypothesis
1998
Nanoparticles functionalised with reversible molecular and supramolecular switches
2010 StandoutNobel
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
The Novel Zinc Finger-Containing Transcription Factor Osterix Is Required for Osteoblast Differentiation and Bone Formation
2002 Standout
Observation of Accelerating Airy Beams
2007 Standout
Preparation and Characterization of Antibodies against Human Ribosomal Proteins: Heterogeneous Expression of S11 and S30 in a Panel of Human Cancer Cell Lines
2000
TET enzymes, TDG and the dynamics of DNA demethylation
2013 StandoutNature
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Major Depressive Disorder
2008 Standout
Developing optofluidic technology through the fusion of microfluidics and optics
2006 StandoutNature
Prospects for MEK inhibitors for treating cancer
2014
Selective Inhibitors of Glutathione Transferase P1 with Trioxane Structure as Anticancer Agents
2015
MUC1/episialin: a critical barrier in the female reproductive tract
2000
Clinical targeting of the TNF and TNFR superfamilies
2013
Therapy with azanucleosides for myelodysplastic syndromes
2010
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
2011 Standout
The PI3K Pathway in Human Disease
2017 Standout
Serotonin Function and the Mechanism of Antidepressant Action
1990
The molecular neurobiology of depression
2008 StandoutNature
Murine HIP/L29 Is a Heparin-binding Protein with a Restricted Pattern of Expression in Adult Tissues
1998
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action
1999
Chimeric antigen receptor T-cell therapies for lymphoma
2017
Current advances and trends in the treatment of depression
1994
Serotoninergic regulation of emotional and behavioural control processes
2007
Heparin-binding EGF-like growth factor interacts with mouse blastocysts independently of ErbB1: a possible role for heparan sulfate proteoglycans and ErbB4 in blastocyst implantation
1999
Targeting the mTOR Signaling Network for Cancer Therapy
2009
THE GREEN FLUORESCENT PROTEIN
1998 StandoutNobel
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
New Ways to Use DNA Methyltransferase Inhibitors for the Treatment of Myelodysplastic Syndrome
2011
Bone Development
2000
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
A revolution in optical manipulation
2003 StandoutNature
Role of Glutathione in Cancer Progression and Chemoresistance
2013
Treatment of Hematologic Malignancies with Immunotoxins and Antibody-Drug Conjugates
2011
Composite Au Nanostructures for Fluorescence Studies in Visible Light
2010 StandoutNobel
Chimeric Antigen Receptor Therapy
2018 Standout
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Ribosome Components Are Associated with Sites of Transcription
2002 StandoutNobel
An Unbiased cDNA Library Prepared from IsolatedAplysiaSensory Neuron Processes Is Enriched for Cytoskeletal and Translational mRNAs
2003 StandoutNobel
A Functional Role for Intra-Axonal Protein Synthesis during Axonal Regeneration from Adult Sensory Neurons
2001
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
New directions in single-molecule imaging and analysis
2007 StandoutNobel
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
2016 StandoutNobel
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
MATRIX PROTEOGLYCANS: From Molecular Design to Cellular Function
1998 Standout
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
Assembly of Polygonal Nanoparticle Clusters Directed by Reversible Noncovalent Bonding Interactions
2009 StandoutNobel
Serotonin receptor knockouts: A moody subject
1998 StandoutNobel
Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants
2003 StandoutScience
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region
1996 StandoutScience
CAR T cell immunotherapy for human cancer
2018 StandoutScience
THE UBIQUITIN SYSTEM
1998 StandoutNobel
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Principles and Implementations of Dissipative (Dynamic) Self-Assembly
2006
“Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates
2017 StandoutNobel
Works of Scott E. Smith being referenced
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
cDNA Cloning and Expression of HIP, a Novel Cell Surface Heparan Sulfate/Heparin-binding Protein of Human Uterine Epithelial Cells and Cell Lines
1996
Expression of Heparan Sulfate Proteoglycan (Perlecan) in the Mouse Blastocyst Is Regulated during Normal and Delayed Implantation
1997
Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)
2012
Ultrastructural morphometric analysis of the uterine epithelium during early pregnancy in the sheep
1990
Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trial
2008
Analysis of very elderly (≥80 years) non‐hodgkin lymphoma: impact of functional status and co‐morbidities on outcome
2011
Phase II study of the oral MEK inhibitor selumetinib (AZD6244) in advanced acute myeloid leukemia (AML).
2012
A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate‐1 risk myelodysplastic syndrome
2011
Micromanipulation in assisted reproduction: a review of current technology
1998
Prevention of Nausea and Vomiting Associated with Stem Cell Transplant: Results of a Prospective, Randomized Trial of Aprepitant Used with Highly Emetogenic Preparative Regimens
2012
Results of a Pivotal Phase 2 Study of Brentuximab Vedotin (SGN-35) in Patients with Relapsed or Refractory Hodgkin Lymphoma
2010
Tryptophan depletion causes a rapid lowering of mood in normal males
1985
A test of possible cognitive and environmental influences on the mood lowering effect of tryptophan depletion in normal males
1987
Results from a pivotal phase II study of brentuximab vedotin (SGN-35) in patients with relapsed or refractory Hodgkin lymphoma (HL).
2011
Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndrome
2009
Activity of single agent temsirolimus (CCI-779) in non-mantle cell non-Hodgkin lymphoma subtypes
2008
Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma
2014
Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium
2010
Aprepitant Vs. Placebo Plus Oral Ondansetron and Dexamethasone for the Prevention of Nausea and Vomiting Associated with Highly Emetogenic Preparative Regimens Prior to Hematopoietic Stem Cell Transplantation: A Prospective, Randomized Double-Blind Phase III Trial.
2009
Expression of the Heparan Sulfate Proteoglycan, Perlecan, during Mouse Embryogenesis and Perlecan Chondrogenic Activity In Vitro
1999
Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma
2016